logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

David T. Rubin

University of Chicago Medicine
H指数:87
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Guselkumab in Patients with Crohn's Disease and Ulcerative Colitis: A Prospective Real-World Study

guselkumab在克罗恩病和溃疡性结肠炎患者中的有效性与安全性：一项前瞻性真实世界研究

Clinical Gastroenterology and Hepatology
IF12
2026-10-230
PRE
Asher Shafrir; David Choi; Lauren C. Capucci; Alexandra Hannett; Jessica Tanouye; Alex J. Mathew; Navneet Natt; Sushila Dalal; Benjamin D. McDonald; Noa Krugliak Cleveland; Joel Pekow; Tenzin Choden; Russell D. Cohen; David T. Rubin
IOIBD: the International Organization for the Study of Inflammatory Bowel Disease

IOIBD：国际炎症性肠病研究组织

Therapeutic Advances in Gastroenterology
IF3.4
2026-08-020
PRE
Iris Dotan; Marla C. Dubinsky; Corey A. Siegel; James Lindsay; Dermot McGovern; Matthieu Allez; Pär Myrelid; James Lewis; Bruce E. Sands; Laurent Peyrin-Biroulet; Silvio Danese; Vineet Ahuja; Gilaad G. Kaplan; Marischka Konings; Richard Gearry; Siew C. Ng; Vipul Jairath; Fernando Magro; Mark S. Silverberg; Dan Turner; Maria T. Abreu; Ailsa Hart; Axel Dignass; David T. Rubin;
Global Roll-Out and Continued Multi-Site Validation of the Artificial Intelligence Histology Instrument for Qualitative Assessment of Histopathology in Ulcerative Colitis

全球推广及人工智能组织学仪器在溃疡性结肠炎组织病理学定性评估中的多中心持续验证

United European Gastroenterology Journal
IF6.7
2026-07-300
OAAI
Laurent Peyrin-Biroulet; Olga Kubassova; Jon Himoff; Christopher R. Weber; Shashi Adsul; Marcelo Freire; Bader E. Hussaini; Luc Biedermann; Viktor H. Koelzer; Brian Bressler; Wei Xiong; Jan H. Niess; Matthias S. Matter; Uri Kopylov; Iris Barshack; Chen Mayer; Fernando Magro; Fatima Carneiro; Nitsan Maharshak; Ariel Greenberg; David T. Rubin
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments

与生物制剂治疗相比，美国溃疡性结肠炎患者使用托法替布治疗发生严重感染、心肌梗死、中风和血栓栓塞事件的风险

Inflammatory Bowel Diseases
IF4.3
2026-07-280
OAAI
David T Rubin, MD; Stefan Schreiber, MD; Laurent Peyrin-Biroulet, MD; Silvio Danese, MD, PhD; Milena A Gianfrancesco, PhD; Arif Soonasra, PharmD; Sarah Sidhu, MD; Ivana Vranic, MD; Ahmed Shelbaya, MD, MPH; David Gruben, PhD; Yuqin Wei, MS; Kevin L Winthrop, MD, MPH; Jeffrey R Curtis, MD, MS, MPH; Miguel D Regueiro, MD; Marla C Dubinsky, MD
The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical program

Etrasimod作为溃疡性结肠炎一线先进疗法的有效性与安全性：ELEVATE UC临床计划中预设及事后分析亚组数据

Therapeutic Advances in Gastroenterology
IF3.4
2026-07-270
PRE
David T. Rubin; Charlie W. Lees; Filip Baert; Maria Kudela; Abhishek Bhattacharjee; Krisztina Lazin; Martina Goetsch; Arcangelo M. Abbatemarco; Karolina Wosik; John K. Marshall
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensus

是时候重新思考炎症性肠病临床试验中的清洗期：一项国际德尔菲共识

Journal of Crohn's and Colitis
IF8.7
2026-05-010
PRE
Pauline Wils; Vipul Jairath; Bruce E Sands; Axel Dignass; Fernando Magro; David T Rubin; Iris Dotan; Walter Reinisch; Parambir Dulai; Richard Gearry; Christopher Ma; Millie Long; Alessandro Armuzzi; Taku Kobayashi; Dan Turner; Sophie Vieujean; Bram Verstockt; Ailsa Hart; Silvio Danese; Laurent Peyrin-Biroulet
Long-term Safety of Upadacitinib in Patients with Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies

乌帕替尼在炎症性肠病患者中的长期安全性：2/3期研究综合分析

Clinical Gastroenterology and Hepatology
IF12
2026-02-270
OAAI
Remo Panaccione; Julián Panés; Laurent Peyrin-Biroulet; Jean-Frédéric Colombel; James O. Lindsay; Filip Baert; Raja Atreya; Séverine Vermeire; Toshimitsu Fujii; Elena Dubcenco; Justin Klaff; Benjamin Duncan; Smitha Suravaram; Irina Fish; Ana P. Lacerda; Ramona Vladea; Sharanya Ford; Saajan Shah; Samuel I. Anyanwu; David T. Rubin
DESI Strong Lens Foundry. I. HST Observations and Modeling with GIGA-Lens

德西强透镜铸造厂。I.用千兆透镜进行HST观测和建模

The Astrophysical Journal
IF0
2026-02-030
OAAI
Xiaosheng Huang; Saul Baltasar; N. Ratier-Werbin; C. Storfer; W. Sheu; S. Agarwal; M. Tamargo-Arizmendi; D.J. Schlegel; J. Aguilar; S. Ahlen; G. Aldering; S. Banka; S. BenZvi; D. Bianchi; A. Bolton; D. Brooks; A. Cikota; T. Claybaugh; A. de la Macorra; A. Dey; P. Doel; J. Edelstein; A. Filipp; J. E. Forero-Romero; E. Gazta ñaga; S. Gontcho A Gontcho; A. Gu; G. Gutierrez; K. Honscheid; E. Jullo; S. Juneau; R. Kehoe; D. Kirkby; T. Kisner; A. Kremin; K.J. Kwon; A. Lambert; M. Landriau; D. Lang; L. Le Guillou; J. Liu; A. Meisner; R. Miquel; J. Moustakas; A. D. Myers; S. Perlmutter; I. Pérez-Ràfols; F. Prada; G. Rossi; D. Rubin; E. Sanchez; M. Schubnell; Y. Shu; E. Silver; D. Sprayberry; N. Suzuki; G. Tarlé; B.A. Weaver; H. Zou
Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis

10年奥扎尼妥治疗的长期能量安全性：来自中重度溃疡性结肠炎或复发性多发性硬化症患者临床试验的结果

Inflammatory Bowel Diseases
IF4.3
2026-02-010
PRE
Rubin, David T.; Danese, Silvio; Nakase, Hiroshi; Ungaro, Ryan C.; Wolf, Douglas C.; Alekseeva, Olga; Petersen, AnnKatrin; Liu, Zhaohui; Mehra, Dimpy; Jain, Anjali; Osterman, Mark T.; Krakovich, Anthony; Riolo, Jon, V; DeBoer, Erik; Appio, James; Sinh, Preetika; Cree, Bruce A. C.; Cohen, Jeffrey A.; Irving, Peter
Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)

奥贝非齐莫德在患有中度至重度活动性溃疡性结肠炎患者中的疗效与安全性：来自两项为期8周的诱导治疗期3期、随机、双盲、安慰剂对照试验（ABTECT-1和2）的结果

AMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
2025-12-010
PRE
Sands, Bruce E.; Danese, Silvio; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Hisamatsu, Tadakazu; Tilg, Herbert; Atreya, Raja; Armuzzi, Alessandro; Treton, Xavier; Baert, Filip; Seidler, Ursula; Cataldi, Fabio; Jacobstein, Doug; Rabbat, Christopher J.; Shan, Kejia; Duvall, George Aaron; Siegmund, Britta; Dulai, Parambir S.; Rubin, David; Vermeire, Severine
Colonic Tissue Expression of MAdCAM-1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease

炎症性肠病中结肠组织MAdCAM-1的表达不能预测 Vedolizumab 的应答情况

CTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
2025-11-240
OAAI
Reddy, Nikhil; Klein, Jeremy A.; Thomas, Nikita; Micic, Dejan; Deng, Zifeng; Rubin, David T.; Cohen, Russell D.; Dalal, Sushila; Christensen, Britt; Haider, Haider I.; Valuckaite, Vesta; Meckel, Katherine R.; Bissonnette, Marc; Weber, Christopher R.; Pekow, Joel

研究方向

暂未获取到该数据
R
Russell D. Cohen
H 指数:54论文数:384被引数:1.2万
S
Silvio Danese
H 指数:139论文数:2,349被引数:8.7万
R
Remo Panaccione
H 指数:106论文数:1,328被引数:6.1万
N
Noa Krugliak Cleveland
H 指数:18论文数:140被引数:1,129
L
Laurent Peyrin‐Biroulet
H 指数:137论文数:2,106被引数:8.7万
J
Joel Pekow
H 指数:42论文数:323被引数:5,483
B
Bruce E. Sands
H 指数:107论文数:1,079被引数:6.5万
S
Sushila Dalal
H 指数:30论文数:182被引数:3,298
M
Marla C. Dubinsky
H 指数:83论文数:898被引数:3.5万
A
Atsushi Sakuraba
H 指数:40论文数:268被引数:6,004